LBRX · Lb Pharmaceuticals Inc
$47.39
+0.16 (+0.34%)
At close · Aug 21
Market Cap
$1.58B
Shares
32.26M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-07-29 | 2026-07-28 | |
| 8-K | 2026-07-22 | — | |
| Investor Event Transcript | 2026-06-16 | 2026-06-30 | |
| 8-K | 2026-06-10 | 2026-06-08 | |
| 8-K | 2026-06-09 | 2026-06-03 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-23 | 2026-06-03 | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-26 | — | |
| 8-K | 2026-03-16 | 2026-03-13 | |
| 8-K | 2026-03-10 | 2026-03-04 | |
| 8-K | 2026-02-05 | 2026-02-04 | |
| 8-K | 2025-11-13 | 2025-11-10 | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-09-12 | — |
Showing 1–21 of 21 filings
Key facts
CIK
1691082
CUSIP
50180M108
13F (30d)
113 filings
112 filers
Visit website
Investor relations